Compare Johnson & Johnson (JNJ) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Clear Secure Inc — how do they compare? Johnson & Johnson trades at $261.19 (market cap $626.09B), while Clear Secure Inc trades at $46.53 (market cap $4.98B). The key difference: Johnson & Johnson is far larger — about 125.7× Clear Secure Inc's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| JNJ | YOU | |
|---|---|---|
Market Cap | $626.09B | $4.98B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $62.36 |
52-Week Low | $172.78 | $29.61 |
Enterprise Value | $654.37B | $4.13B |
Dividend Yield | 2.06% | 1.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
CLEAR Secure (YOU) trades at $46.98, down 8.26% in 24 hours, reflecting recent bearish pressure but holding above key support at $45. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $0.49 per share, revenue growth to $1.0 billion in 2026, and robust profitability margins. Technical indicators are mixed, with moving averages bearish but oscillators like RSI suggesting potential oversold conditions. Recent news highlights expansion in identity verification services and corporate memberships.
Outlook is cautiously optimistic due to earnings beats and growth initiatives, but risks include high valuation multiples and market volatility. Analysts are divided with a near-even buy/hold split, indicating balanced sentiment. Investors should weigh strong operational cash flow against competitive pressures in the identity security sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
